🔥🐔 BizChicken 🐔🔥
Companies Similar to Kronos Bio, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
Entero Therapeutics, Inc.
latiglutenase
First Wave Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and non-systemic therapies for gastrointestinal diseases, including treatments for celiac disease, fat digestion, gastroparesis, and inflammatory bowel diseases.
Symbol: ENTO
Recent Price: $0.62
Industry: Biotechnology
CEO: Mr. James R. Sapirstein M.B.A., R.Ph.
Sector: Healthcare
Employees: 9
Address: 777 Yamato Road, Boca Raton, FL 33431
Phone: (561) 589-7020
Last updated: 2024-12-31
Kronos Bio, Inc.
entospletinib (ENTO)
Kronos Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel cancer therapeutics targeting dysregulated transcription factors. It is developing product candidates like entospletinib for acute myeloid leukemia and KB-0742 for MYC-amplified solid tumors.
Symbol: KRON
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Norbert W. Bischofberger Ph.D.
Sector: Healthcare
Employees: 58
Address: 1300 South El Camino Real, San Mateo, CA 94402
Phone: 650 781 5200
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Statera Biopharma, Inc.
STAT-201, Entolimod, STAT-401, STAT-205
Statera Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to treat autoimmune diseases, cancers, and infectious diseases by rebalancing the immune system.
Symbol: STAB
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Michael Kevin Handley
Sector: Healthcare
Employees: 46
Address: 2537 Research Boulevard, Fort Collins, CO 80526
Phone: 888 613 8802
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Zentalis Pharmaceuticals, Inc.
ZN-c3, ZN-c5
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for treating various cancers. Its leading product candidates include ZN-c3 and ZN-c5, which are in various phases of clinical trials targeting specific cancer types.
About | About | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: ZNTL
Recent Price: $2.92
Industry: Biotechnology
CEO: Dr. Kimberly Lynn Blackwell M.D.
Sector: Healthcare
Employees: 124
Address: 1359 Broadway, New York, NY 10018
Phone: 212 433 3791
Last updated: 2024-12-31
Atossa Therapeutics, Inc.
Endoxifen
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for oncology and infectious diseases with key programs in breast cancer and COVID-19 treatment.
Symbol: ATOS
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Steven C. Quay FCAP, M.D., Ph.D.
Sector: Healthcare
Employees: 12
Address: 107 Spring Street, Seattle, WA 98104
Phone: 206 588 0256
Last updated: 2024-12-31
Coherus BioSciences, Inc.
UDENYCA
Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.
Symbol: CHRS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Dennis M. Lanfear
Sector: Healthcare
Employees: 306
Address: 333 Twin Dolphin Drive, Redwood City, CA 94065
Phone: 650 649 3530
Last updated: 2024-12-31
Curis, Inc.
Emavusertib
Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.
About | Management | Directors | About | About | Contact | Contact | Contact | About | Careers | Careers | Benefits | About | About | About | About | Jobs | About
Symbol: CRIS
Recent Price: $3.14
Industry: Biotechnology
CEO: Mr. James E. Dentzer
Sector: Healthcare
Employees: 49
Address: Building C, Lexington, MA 02421
Phone: 617 503 6500
Leadership
- Martyn D. Greenacre, Chair of the Board
- John Hohneker, M.D., Director
- Kenneth I. Kaitin, Ph.D., Director
- Anne E. Borgman, M.D., Director
- Marc Rubin, M.D., Director
- James Dentzer, Chief Executive Officer and Director
Last updated: 2024-12-31
Ensysce Biosciences, Inc.
PF614, PF614-MPAR, PF329
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company focused on developing prescription drugs for severe pain relief and opioid overdose protection using proprietary abuse-resistant technologies.
Symbol: ENSC
Recent Price: $8.62
Industry: Biotechnology
CEO: Dr. D. Lynn Kirkpatrick Ph.D.
Sector: Healthcare
Employees: 7
Address: 7946 Ivanhoe Avenue, La Jolla, CA 92037
Phone: 858 263 4196
Last updated: 2024-12-31
iTeos Therapeutics, Inc.
inupadenant, EOS-448
Iteos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of immuno-oncology therapeutics. Their product pipeline includes inupadenant and EOS-448, which are in various phases of clinical trials.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About | About | About | About
Symbol: ITOS
Recent Price: $7.29
Industry: Biotechnology
CEO: Dr. Michel Detheux Ph.D.
Sector: Healthcare
Employees: 157
Address: 321 Arsenal Street, Cambridge, MA 02472-5710
Phone: 339 217 0161
Leadership
- Michel DETHEUX, President, Chief Executive Officer
- Matt CALL, Chief Operating Officer
- Matthew GALL, Chief Financial Officer
- Yvonne MCGRATH, Chief Scientific Officer
- David Feltquate, Chief Medical Officer
- Philippe BRANTEGEM, Executive Vice President of Human Resources
- Adi OSOVSKY, Executive Vice President of Legal
- David HALLAL, Chair of the Board
- Aaron DAVIS,
- Jill DESIMONE,
- David LEE,
- Tim VAN HAUWERMEIREN,
- Tony HO,
- Robert IANNONE,
- Ann RHOADS,
Last updated: 2024-12-31
Kura Oncology, Inc.
ziftomenib and tipifarnib
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company developing small molecule medicines for the treatment of cancer. It focuses on genetically defined subsets of acute leukemias and has a collaboration with Novartis for certain carcinoma treatments.
Symbol: KURA
Recent Price: $8.51
Industry: Biotechnology
CEO: Dr. Troy Edward Wilson J.D., Ph.D.
Sector: Healthcare
Employees: 142
Address: 12730 High Bluff Drive, San Diego, CA 92130
Phone: 858 500 8800
Last updated: 2024-12-31
Phio Pharmaceuticals Corp.
INTASYL therapeutic platform
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.
Symbol: PHIO
Recent Price: $1.90
Industry: Biotechnology
CEO: Mr. Robert J. Bitterman
Sector: Healthcare
Employees: 8
Address: 257 Simarano Drive, Marlborough, MA 01752
Phone: 508 767 3861
Last updated: 2024-12-31
Instil Bio, Inc.
ITIL-168, ITIL-306
Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops cell therapies for treating cancer patients, focusing on autologous tumor infiltrating lymphocyte (TIL) treatments.
Symbol: TIL
Recent Price: $18.99
Industry: Biotechnology
CEO: Mr. Bronson Crouch
Sector: Healthcare
Employees: 49
Address: 3963 Maple Avenue, Dallas, TX 75219
Phone: 972 499 3350
Last updated: 2024-12-31
Vor Biopharma Inc.
VOR33
Vor Biopharma, Inc. is a clinical-stage company focused on developing engineered hematopoietic stem cell (e HSC) therapies for cancer patients, with a leading product, VOR33, in phase 1/2 trials for AML and other hematological malignancies.
About | Vision/Values | About | Leadership | Directors | About | About | Contact | Contact | News | Careers | About | About | About
Symbol: VOR
Recent Price: $1.19
Industry: Biotechnology
CEO: Dr. Robert Ang M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 168
Address: 100 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 655 6580
Leadership
- Robert Ang, MBBS, MBA, President and Chief Executive Officer
- Eyal Attar, MD, Chief Medical Officer
- Tirtha Chakraborty, PhD, Chief Scientific Officer
- Han Choi, MD, LLM, Chief Financial Officer
- John King, MBA, Chief Commercial Officer and Head of Business Development
- Tania Philipp, Chief People Officer
- David Phillips, MBA, Senior Vice President, Head of Quality
- Samir Vattompadam, MS, Senior Vice President, Portfolio Strategy and Program Management
- Daniella Beckman, Board of Directors
- David Lubner, Board of Directors
- Bill Lundberg, MD, Board of Directors
- Fouad Namouni, MD, Board Of Directors
- Matthew R. Patterson, Chairman, Board of Directors
- Josh Resnick, MD, Board of Directors
Last updated: 2024-12-31
Xencor, Inc.
Monoclonal Antibody and Cytokine Therapeutics
Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.
About | ESG | Contact | Careers | Careers | About | Events | About | About | About | Contact | Management | About | Directors | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers
Symbol: XNCR
Recent Price: $23.71
Industry: Biotechnology
CEO: Dr. Bassil I. Dahiyat Ph.D.
Sector: Healthcare
Employees: 280
Address: 111 West Lemon Avenue, Monrovia, CA 91016
Phone: 626 305 5900
Last updated: 2024-12-31
Arcus Biosciences, Inc.
Cancer Therapies
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.
About | About | Leadership | Directors | About | Contact | Contact | Contact | Contact | Contact | Careers | About | About | About | About | Careers | About | Jobs | About | About
Symbol: RCUS
Recent Price: $14.91
Industry: Biotechnology
CEO: Dr. Terry J. Rosen Ph.D.
Sector: Healthcare
Employees: 577
Address: 3928 Point Eden Way, Hayward, CA 94545
Phone: 510 694 6200
Last updated: 2024-12-31
Enanta Pharmaceuticals, Inc.
N/A
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases, with targets including respiratory syncytial virus, SARS-Co V-2, human metapneumovirus, and hepatitis B virus.
About | Leadership | Directors | Contact | Careers | Careers | Culture | About | About | About
Symbol: ENTA
Recent Price: $5.85
Industry: Biotechnology
CEO: Dr. Jay R. Luly Ph.D.
Sector: Healthcare
Employees: 145
Address: 500 Arsenal Street, Watertown, MA 02472
Phone: 617 607 0800
Leadership
- Jay R. Luly, Ph.D., President, Chief Executive Officer and Director
- Tara L. Kieffer, Ph.D., Chief Product Strategy Officer
- Matthew P. Kowalsky, J.D., Chief Legal Officer
- Brendan Luu, Chief Business Officer
- Paul J. Mellett, Chief Financial and Administrative Officer
- Yat Sun Or, Ph.D., Chief Scientific Officer
- Scott T. Rottinghaus, M.D., Chief Medical Officer
- Bruce L.A. Carter, Ph.D., Chairman of the Board
- Mark G. Foletta, Board Member
- Yujiro S. Hata, Board Member
- Kristine Peterson, Board Member
- Lesley Russell, MBChB, MRCPb, Board Member
- Terry Vance, Board Member
Last updated: 2024-12-31